Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
7 drugs in development
By Therapeutic Area
top 2
R&D Momentum
68/100
Pipeline Velocity
37/100
Trial Completion Rate
56/100
Pipeline Concentration
59/100
Pipeline Freshness
73/100
Strategic Signals
Activity
Last 14 days
Mental Processes for Rating Pain Intensity
Study of Fetal Health Outcomes: Working With a Missouri E-telehealth Platform
Sleep as a Mechanism of Change in Alcohol Use Outcomes Among Heavy-Drinking Adults
Comparing the Anesthetic Effect of Warmed Lidocaine to Room Temperature Lidocaine When Applied Topically for Intravitreal Injections
The Impact of Insomnia Treatment on Heavy Alcohol Use Among Returning Veterans
Biometabolic Impact of Continuation of GLP-1 Agonists Following Bariatric
Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women
Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)